Procter & Gamble Company (The) (NYSE:PG) Shares Bought by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. boosted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 169,606 shares of the company's stock after purchasing an additional 10,396 shares during the quarter. Stratos Wealth Partners LTD.'s holdings in Procter & Gamble were worth $28,904,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $5,244,463,000. GAMMA Investing LLC increased its holdings in shares of Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after purchasing an additional 7,913,335 shares during the last quarter. Capital Research Global Investors increased its holdings in shares of Procter & Gamble by 62.5% in the fourth quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock valued at $1,240,294,000 after purchasing an additional 2,846,560 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Procter & Gamble by 10.1% in the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock valued at $4,928,107,000 after purchasing an additional 2,703,757 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Procter & Gamble by 15.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after purchasing an additional 2,224,912 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Raymond James Financial cut their price target on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating for the company in a report on Friday, April 25th. Morgan Stanley set a $180.00 target price on Procter & Gamble and gave the stock an "overweight" rating in a research note on Friday, April 25th. JPMorgan Chase & Co. cut their target price on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Bank of America cut their target price on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Finally, Redburn Partners set a $161.00 target price on Procter & Gamble in a research note on Thursday, May 1st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $178.45.

Insider Transactions at Procter & Gamble

In other news, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer owned 51,965 shares in the company, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of Procter & Gamble stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the sale, the insider owned 25,182 shares in the company, valued at $3,995,627.94. This trade represents a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by insiders.

Procter & Gamble Stock Up 0.6%

NYSE PG traded up $0.94 during trading on Thursday, reaching $158.46. 5,709,649 shares of the company's stock were exchanged, compared to its average volume of 7,576,852. The stock has a market cap of $371.52 billion, a P/E ratio of 25.15, a price-to-earnings-growth ratio of 4.49 and a beta of 0.40. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.50 and a current ratio of 0.71. The company has a 50 day moving average price of $161.87 and a two-hundred day moving average price of $165.09. Procter & Gamble Company has a 1 year low of $155.95 and a 1 year high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. The company had revenue of $19.78 billion during the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. Procter & Gamble's revenue for the quarter was down 2.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.52 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date is Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is currently 67.14%.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.